Cellestia.com
Visit cellestia.com-
7 months ago
Last scanned
-
12 years
Domain Age
-
No data
Daily Visitors
-
No data
Global Rank
Cellestia.com
Visit cellestia.com
About Website
Updated:
Cellestia
Cellestia Biotech is pioneering innovative therapeutics based on novel modes of action to treat autoimmune diseases and multi-drug resistant cancers. Our clinical stage drug candidate, CB-103, has demonstrated both safety and biological activity in humans. Along with ongoing Phase 2 IITs for multi-drug resistant cancers, CB-103 is also poised to enter a Proof-of-Concept clinical study for graft-versus-host disease (GvHD)
Network Data
This website is hosted with Bertrand Emmanuel, which reserves the following IP addresses for cellestia.com: 176.31.68.81. Moreover, DNS used with this website include ns1.cyon.ch, ns2.cyon.ch.
-
7 months ago
Last scanned
-
12 years
Domain Age
-
No data
Daily Visitors
-
No data
Global Rank
Network
ADDRESSING DETAILS
-
Hosting Company
-
IPs
-
DNS
ns1.cyon.ch
ns2.cyon.ch
Whois
OWNERSHIP
-
Created
2011-10-03
-
Expires
2023-10-03
-
Owner
REDACTED FOR PRIVACY
-
Registar
KEY-SYSTEMS GMBH
-
Owner Emails
mail@cyon.ch, info@domain-contact.org
Domain & Keywords
The registrar of cellestia.com is KEY-SYSTEMS GMBH and the name expires on 2023-10-03. According to open source data, you can reach the owner at mail@cyon.ch but please make sure you have a good reason for unsolicited messages. Their country of residence is REDACTED FOR PRIVACY.
- Medical
- cancer treatment
- Notch
- cancer
- Pharma
- biotech
- biopharmaceutical
- Douglas Hanahan
- CB103
- cellestia
Websites similar to cellestia.com
-
wmtctaiwan.com-
Global rank
N/A
-
Daily Visitors
N/A
-
-
seroba-lifesciences.com-
Global rank
N/A
-
Daily Visitors
N/A
-
-
thoughtleaderselect.com-
Global rank
N/A
-
Daily Visitors
N/A
-
-
metabolism.com-
Global rank
N/A
-
Daily Visitors
N/A
-
-
biomarker-innovations.com
-
Global rank
N/A
-
Daily Visitors
N/A
-